TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Children’s Oncology Group Study Shows Improved Care For Childhood Brain Tumors October 31, 2008
TCL Archive Researchers Feel Impact of Shutdown As Grant Review Stops, Funding Runs Dry January 5, 1996
TCL Archive ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies July 13, 1984